Synthesis of 1H-imidazo[1,2-b]-1,2,4-triazol-6-amines via multicomponent reaction. 2007

Yan Huang, and Xiu-Qin Hu, and Da-Peng Shen, and Yong-Fei Chen, and Peng-Fei Xu
State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, P.R. China.

A simple and effective method for the synthesis of bioactive imidazo[1,2,4]triazole analogues has been developed utilizing the MCR technique, which involved the reaction of aminotriazoles, isocyanides and aldehydes. The products were characterized by (1)H, (13)C NMR spectroscopy, MS and elemental analysis. Interestingly, compounds 19d, 21a, 21b and 21h displayed good cytotoxic activities at 10(-4) M concentration in the inhibition of tumor cell growth as evaluated by the MTT method.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Yan Huang, and Xiu-Qin Hu, and Da-Peng Shen, and Yong-Fei Chen, and Peng-Fei Xu
January 2014, Beilstein journal of organic chemistry,
Yan Huang, and Xiu-Qin Hu, and Da-Peng Shen, and Yong-Fei Chen, and Peng-Fei Xu
March 1989, Journal of medicinal chemistry,
Yan Huang, and Xiu-Qin Hu, and Da-Peng Shen, and Yong-Fei Chen, and Peng-Fei Xu
February 2021, Molecular diversity,
Yan Huang, and Xiu-Qin Hu, and Da-Peng Shen, and Yong-Fei Chen, and Peng-Fei Xu
October 2013, ACS combinatorial science,
Yan Huang, and Xiu-Qin Hu, and Da-Peng Shen, and Yong-Fei Chen, and Peng-Fei Xu
August 2005, The Journal of organic chemistry,
Yan Huang, and Xiu-Qin Hu, and Da-Peng Shen, and Yong-Fei Chen, and Peng-Fei Xu
September 2011, Acta crystallographica. Section E, Structure reports online,
Yan Huang, and Xiu-Qin Hu, and Da-Peng Shen, and Yong-Fei Chen, and Peng-Fei Xu
June 2023, iScience,
Yan Huang, and Xiu-Qin Hu, and Da-Peng Shen, and Yong-Fei Chen, and Peng-Fei Xu
July 1985, Il Farmaco; edizione scientifica,
Yan Huang, and Xiu-Qin Hu, and Da-Peng Shen, and Yong-Fei Chen, and Peng-Fei Xu
October 2021, The Journal of organic chemistry,
Yan Huang, and Xiu-Qin Hu, and Da-Peng Shen, and Yong-Fei Chen, and Peng-Fei Xu
May 2015, Molecular diversity,
Copied contents to your clipboard!